Dechra Pharmaceuticals Claimed Company
Dechra is an international specialist veterinary pharmaceuticals and related products business. read more
HR or Marketing? Claim Your Free Employer Account
Dechra Pharmaceuticals Investor Relations Salary
The average Dechra Pharmaceuticals Investor Relations earns an estimated $84,787 annually. Dechra Pharmaceuticals' Investor Relations compensation is $2,857 more than the US average for a Investor Relations.
Last updated 2 years ago.
$35k
$47k
$63k
$70k
$109k
$139k
$168k
$84,787
Average Compensation
- $84,787
- avg. base
Investor Relations Salaries at Dechra Pharmaceuticals
Compensation at Dechra Pharmaceuticals by Department
How Investor Relations at Dechra Pharmaceuticals Rate Their Compensation
The majority of Investor Relations at Dechra Pharmaceuticals believe they're compensated fairly. The vast majority (75%) of Investor Relations at Dechra Pharmaceuticals are satisfied with their benefits. See more compensation ratings at Dechra Pharmaceuticals
Investor Relations Salaries at Similar Size Companies
×